Bristol-Myers Squibb CoMIL:1BMY +3.55%50 FCF Yield % is 9.74 as of Jul. 03, 2026, which is 12% above its 10-year median of 8.68. GuruFocus rates MIL:1BMY with a GF Score™ of 50/100 and a GF Value™ of €47.54 (Fairly Valued). The stock has 6 warning signs investors should review. Among 1,006 Drug Manufacturers companies, Bristol-Myers Squibb Co ranks better than 88.27% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Bristol-Myers Squibb Co FCF Yield % Related Terms
Bristol-Myers Squibb Co FCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MIL:1BMY vs PFE, GILD, AMGN: FCF Yield % Comparison
For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bristol-Myers Squibb Co FCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Bristol-Myers Squibb Co's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bristol-Myers Squibb Co (MIL:1BMY) has a FCF Yield % of 9.74 as of Jul. 03, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Bristol-Myers Squibb Co and its competitors. This is 12% above median its historical median of 8.68. Over the past decade, Bristol-Myers Squibb Co's FCF Yield % has ranged from 0.47 to 17.20. According to the industry distribution chart, Bristol-Myers Squibb Co ranks #118 out of 1006 companies in the Drug Manufacturers industry, placing it in the top 11.7%.
Is Bristol-Myers Squibb Co's FCF Yield % too high?
Bristol-Myers Squibb Co's current FCF Yield % of 9.74 is 12% above median its 10-year median of 8.68. Over the past 10 years, this metric has ranged from a low of 0.47 to a high of 17.20. The Drug Manufacturers industry median FCF Yield % is 0.67. Bristol-Myers Squibb Co's value of 9.74 is 1364.7% above this industry median. Based on the distribution chart, Bristol-Myers Squibb Co ranks #118 out of 1006 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Bristol-Myers Squibb Co has a GF Score™ of 50/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bristol-Myers Squibb Co's FCF Yield % compare to PFE and GILD?
According to the Drug Manufacturers industry distribution chart, Bristol-Myers Squibb Co ranks #118 out of 1006 companies for FCF Yield %. This places Bristol-Myers Squibb Co in the top 12% of its industry — outperforming the majority of peers. The industry median FCF Yield % is 0.67. Bristol-Myers Squibb Co's value of 9.74 is 1364.7% above this benchmark. Historically, Bristol-Myers Squibb Co's own FCF Yield % has ranged from 0.47 to 17.20 over the past decade. While the company's 10-year median is 8.68 vs. the industry median of 0.67, Bristol-Myers Squibb Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.67, based on 1,006 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bristol-Myers Squibb Co's current FCF Yield % of 9.74 is 1364.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Bristol-Myers Squibb Co and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bristol-Myers Squibb Co's current FCF Yield % is 9.74, which is 12% above median its own 10-year median of 8.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bristol-Myers Squibb Co stock overvalued right now?
Based on GuruFocus' analysis, Bristol-Myers Squibb Co (MIL:1BMY) is currently considered Fairly Valued. The stock's GF Value™ is €47.54, compared to a current price of €50.38 — trading 6% above its estimated fair value. The current FCF Yield % is 9.74, which is 12% above median its 10-year median of 8.68 and 1364.7% above the Drug Manufacturers industry median of 0.67. Bristol-Myers Squibb Co's overall GF Score™ is 50/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Bristol-Myers Squibb Co (MIL:1BMY), the current FCF Yield % is 9.74 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bristol-Myers Squibb Co (MIL:1BMY) Overvalued in 2026?
Based on GuruFocus' analysis, Bristol-Myers Squibb Co stock appears to be overvalued.
The current stock price of €50.38 is trading 6% above its estimated GF Value™ of €47.54.
GuruFocus considers Bristol-Myers Squibb Co to be Fairly Valued.
Key valuation signals for MIL:1BMY:
FCF Yield %: 9.74 (12% above median its 10-year median of 8.68)
GF Value™: €47.54 vs. price of €50.38 (6% above fair value)
Industry Position: 1364.7% above the Drug Manufacturers median (#118 of 1006)
No single metric tells the full story. See the MIL:1BMY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
50GF Score
Get the complete analysis for MIL:1BMY
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MIL:1BMY has been successfully added to your 
